ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 108 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $607 | -99.7% | 72,310 | +166.8% | 0.03% | -50.9% |
Q4 2020 | $186,000 | -7.5% | 27,100 | 0.0% | 0.05% | -17.2% |
Q3 2020 | $201,000 | +105.1% | 27,100 | +15.2% | 0.06% | +93.9% |
Q2 2020 | $98,000 | +30.7% | 23,530 | -22.7% | 0.03% | +3.1% |
Q1 2020 | $75,000 | -58.1% | 30,450 | +2.0% | 0.03% | -51.5% |
Q2 2019 | $179,000 | -14.8% | 29,840 | +28.6% | 0.07% | -45.0% |
Q1 2019 | $210,000 | -23.1% | 23,209 | -29.5% | 0.12% | +57.9% |
Q4 2018 | $273,000 | +228.9% | 32,934 | +215.9% | 0.08% | +347.1% |
Q2 2018 | $83,000 | – | 10,424 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |